Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Walter, Fried"'
Autor:
Robert B. Epstein, Walter Fried
Publikováno v:
Postgraduate medicine. 55(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48c00ebd56d1cfb6caa6dd81d4490174
https://pubmed.ncbi.nlm.nih.gov/27416501
https://pubmed.ncbi.nlm.nih.gov/27416501
Autor:
Walter Fried
Publikováno v:
Experimental Hematology. 37:1007-1015
Although the concept of a humoral regulator of erythropoiesis was introduced more than 100 years ago, its existence was first firmly established a little more than 50 years ago. This review briefly describes the historical development of information
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6db08ce33f14e12a849789f8e7b03473
https://doi.org/10.1016/j.exphem.2009.05.010
https://doi.org/10.1016/j.exphem.2009.05.010
Publikováno v:
Annals of the New York Academy of Sciences. 77:551-573
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::165932f0d4a6a1fb0fa73e2a91f70156
https://doi.org/10.1111/j.1749-6632.1959.tb36925.x
https://doi.org/10.1111/j.1749-6632.1959.tb36925.x
Publikováno v:
Oncology (Williston Park, N.Y.). 27(2)
Diffuse large B-cell non-Hodgkin lymphoma (DLBCL) is a disease of the elderly, but our current guidelines and treatment paradigms for this disease are based on studies that have mainly enrolled younger patients. Because the number of people living be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4889d08213207ac9ab8861a9893bd5d5
https://pubmed.ncbi.nlm.nih.gov/23530407
https://pubmed.ncbi.nlm.nih.gov/23530407
Autor:
Walter Fried
Publikováno v:
Annual Review of Nutrition. 15:353-377
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04471e2f5637bfd81a63f09b900884a3
https://doi.org/10.1146/annurev.nu.15.070195.002033
https://doi.org/10.1146/annurev.nu.15.070195.002033
Autor:
Kathy Tolzien, Angel G. Galvez, Wendy M. Dewey, Chadi Nabhan, Walter Fried, Nancy Davis, Susan Foss, Jacob D. Bitran, Parameswaran Venugopal
Publikováno v:
Cancer. 117(7)
BACKGROUND: Currently, no standard therapy exists for patients with relapsed and/or refractory non-Hodgkin lymphoma (NHL) who are ineligible for transplantation or who have failed after bone marrow transplantation. The authors of this report investig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3a2acd69a01f1a4c0fc2655509a0864
https://pubmed.ncbi.nlm.nih.gov/21425150
https://pubmed.ncbi.nlm.nih.gov/21425150
Publikováno v:
Journal of the American Academy of Dermatology. 28(5 Pt 1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07c2d296ba381f99d879e320c261f265
https://pubmed.ncbi.nlm.nih.gov/8496428
https://pubmed.ncbi.nlm.nih.gov/8496428
Autor:
Laura Magid, Angel G. Galvez, Jacob D. Bitran, Walter Fried, Kathy Tolzien, Wendy M. Dewey, Parameswaran Venugopal, Chadi Nabhan
Publikováno v:
Blood. 114:921-921
Abstract 921 Background: CLO is a second generation nucleoside analogue with known activity in acute leukemia and myelodysplasia. As there is no standard therapy for refractory and transplant-ineligible relapsed NHL, and given the activity that purin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b47d80485941b4a8a1c4f6bceca000c
https://doi.org/10.1182/blood.v114.22.921.921
https://doi.org/10.1182/blood.v114.22.921.921
Autor:
Jacob D. Bitran, Walter Fried, Chadi Nabhan, Phillip Gozun, Parameswaran Venugopal, Angel G. Galvez
Publikováno v:
Blood. 110:4462-4462
There is no known standard of care for pts with relapsed and/or refractory NHL who cannot undergo stem cell transplantation (SCT) or have relapsed after SCT. Such pts are candidates for new therapies. CLO is a novel nucleoside analogue with known act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8abbe977a30936582e5a01278730093
https://doi.org/10.1182/blood.v110.11.4462.4462
https://doi.org/10.1182/blood.v110.11.4462.4462
Autor:
Richard M. Freeman, Walter Fried, Richard L. DeGowin, Thomas P. Gibson, William W. Bonney, Kenneth K. Wu
Publikováno v:
Archives of Internal Medicine. 132:898-902
Since anemia is one of the main obstacles to optimal rehabilitation of anephric patients supported with hemodialysis, it is ironic that erythrocytosis has proved a troublesome complication in a few patients who have undergone renal transplantation. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::337bed860ec24192841ea2ddfcc8ab74
https://doi.org/10.1001/archinte.132.6.898
https://doi.org/10.1001/archinte.132.6.898